Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van de Werf

Showing results (21-30 of 290) with videos related to

Pageof 29
Sort By:
Circulation|June 15, 1995
Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?F Van de Werf
The New England Journal of Medicine|October 31, 1996
Cardiac troponins in acute coronary syndromesF Van de Werf
Thrombosis Research|September 25, 2001
Thrombolytic therapy. State of the artP Sinnaeve, F Van de Werf
Current Opinion in Cardiology|August 1, 1992
Reperfusion intervention in acute myocardial infarctionM Vrolix, F Van de Werf
European Heart Journal|November 10, 2000
Cardiogenic shock: a call for aggressivenessJ Dens, F van de Werf
Circulation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de Werf
European Heart Journal|November 1, 1985
Coronary thrombolysis with tissue-type plasminogen activator: an overviewF Van de Werf, D Collen
The American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de Werf
Lancet (London, England)|December 21, 1996
Cardiology. Acute coronary syndromes: Virchow's triad revisitedS Janssens, F Van de Werf
Thrombosis and Haemostasis|March 1, 2000
TNK-tPA for acute myocardial infarction: the clinical experienceS V Pislaru, F Van de Werf
Pageof 29

Showing results (21-30 of 290) with videos related to

Sort By:
Pageof 29
Circulation|June 15, 1995
Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?F Van de Werf
The New England Journal of Medicine|October 31, 1996
Cardiac troponins in acute coronary syndromesF Van de Werf
Thrombosis Research|September 25, 2001
Thrombolytic therapy. State of the artP Sinnaeve, F Van de Werf
Current Opinion in Cardiology|August 1, 1992
Reperfusion intervention in acute myocardial infarctionM Vrolix, F Van de Werf
European Heart Journal|November 10, 2000
Cardiogenic shock: a call for aggressivenessJ Dens, F van de Werf
Circulation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de Werf
European Heart Journal|November 1, 1985
Coronary thrombolysis with tissue-type plasminogen activator: an overviewF Van de Werf, D Collen
The American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de Werf
Lancet (London, England)|December 21, 1996
Cardiology. Acute coronary syndromes: Virchow's triad revisitedS Janssens, F Van de Werf
Thrombosis and Haemostasis|March 1, 2000
TNK-tPA for acute myocardial infarction: the clinical experienceS V Pislaru, F Van de Werf
Pageof 29